Managing ADHD in Transition Periods: Listening to the Patient From Diagnosis to Follow-up
Earn CME: https://www.naccme.com/program/pc20-adhd
© 2020 NACCME, an HMP Company
Видео Managing ADHD in Transition Periods: Listening to the Patient From Diagnosis to Follow-up канала ImedexCME
© 2020 NACCME, an HMP Company
Видео Managing ADHD in Transition Periods: Listening to the Patient From Diagnosis to Follow-up канала ImedexCME
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Utilizing Radiofrequency Ablation to Treat Metastatic Bone Disease: A Case-Based Presentation
BED: Revealing Binge Eating Disorder from a Clinical and a Patient Perspective
Advanced NSCLC: Refining Clinical Pathways in the Rapidly Evolving Therapeutic Landscape
Cutaneous Manifestations of COVID-19: Identifying and Distinguishing from Pressure Injuries
Adult ADHD: Patient Perspectives and Best Practice Strategies
Alzheimer's Disease: The Importance of Early Detection and Collaborative Care
Health-System Pharmacy Challenges in Hyperkalemia
Insomnia in Psychiatric Patient Populations: Updates and Considerations for Comprehensive Care
Advances in Anti-Cytokine Therapy for IBD: The Role of IL-12/23 and IL-23 Inhibitors
Diagnosis of Early Alzheimer’s Disease vs. Mild Cognitive Impairment
CLL: BTK Inhibitors in Hematologic Oncology Pathways - Pathway-Guided Choices
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
Leveraging JAK Inhibitors in Ulcerative Colitis: Strategies for the IBD Management Team
How to Write an Effective Research Paper
Optimizing IBD Management: New and Emerging Therapeutic Targets
Could It Be Aspergers?
Approaching MRD in Multiple Myeloma
Hair Loss: Myths and Realities | Carolyn Goh, MD - UCLA Health
Elevating Efficacy with LAIA Treatment in Schizophrenia: A Focus on Administration and Adherence
Vitamin D and COVID 19: The Evidence for Prevention and Treatment of Coronavirus (SARS CoV 2)